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Abstract: The aim of this study was to evaluate the total phenolic and flavonoid content, and the in vitro
antioxidant, anti-inflammatory, antibacterial, antifungal, antimalarial, cytotoxicity, and antiprotozoal
activities of the Algerian plant Cytisus villosus Pourr. (Syn. Cytisus triflorus L’Hérit.). Additionally,
the radioligand displacement affinity on opioid and cannabinoid receptors was assessed for
the extracts and isolated pure compounds. The hydro alcoholic extract of the aerial part of C.
villosus was partitioned with chloroform (CHCl3), ethyl acetate (EtOAc), and n-butanol (n-BuOH).
The phenolic content of the C. villosus extracts was evaluated using a modified Folin–Ciocalteau
method. The total flavonoid content was measured spectrometrically using the aluminum chloride
colorimetric assay. The known flavonoids genistein (1), chrysin (2), chrysin-7-O-β-d-glucopyranoside
(3), and 2”-O-α-l-rhamnosylorientin (4) were isolated. The antioxidant activities of the extracts
and isolated compounds were evaluated using 2,2-diphenyl-1-picrylhydrazyl (DDPH) and cellular
antioxidant activity (CAA) assays. The plant extracts showed moderate antioxidant activity. EtOAc
and n-BuOH extracts showed moderate anti-inflammatory activity through the inhibition of induced
nitric oxide synthase (iNOS) with IC50 values of 48 and 90 µg/mL, respectively. The isolated pure
compounds 1 and 3 showed good inhibition of Inducible nitric oxide synthase (iNOS) with IC50
values of 9 and 20 µg/mL, respectively. Compounds 1 and 2 exhibited lower inhibition of Nuclear
Factor kappa-light-chain-enhancer of activated B cells (NF-κB) with IC50 values of 28 and 38 µg/mL,
respectively. Furthermore, the extracts and isolated pure compounds have been shown to exhibit
low affinity for cannabinoid and opioid receptors. Finally, n-BuOH extract was a potent inhibitor of
Trypanosoma brucei with IC50 value of 7.99 µg/mL and IC90 value of 12.61 µg/mL. The extracts and
isolated compounds showed no antimicrobial, antimalarial nor antileishmanial activities. No cytotoxic
effect was observed on cancer cell lines. The results highlight this species as a promising source of
anti-inflammatory and antitrypanosomal agents.
Keywords: Cytisus villosus; antioxidant; anti-inflammatory; antibacterial; antifungal; antimalarial;
antileishmanial; antitrypanosomal; cytotoxicity; cannabinoid receptor; opioid receptor
Biomolecules 2019, 9, 732; doi:10.3390/biom9110732 www.mdpi.com/journal/biomolecules
Biomolecules 2019, 9, 732 2 of 16
1. Introduction
Natural compounds derived from plants have played an important role from ancient to recent
times in the management and treatment of many maladies with wide effects, such as antioxidants
associated with reduced risks of cancer, cardiovascular disease, diabetes, infectious diseases, and
other disorders associated with age [1]. The advantage of many natural products, which have been
components of the human diet for several thousand years, is that the human organism has become
adapted to them, which may decrease the risk of harmful side effects.
Polyphenols are a major class of natural compounds of medicinal importance, exhibiting a
wide range of biological and pharmacological activities, such as antioxidant, anti-inflammatory,
immunostimulant, anti-aging, antitumor, antidepressant, and antiparasitic [2,3]. The high antioxidant
activity of polyphenols is mainly due to their redox properties, which allow them to act as reducing
agents, hydrogen donors, and singlet oxygen quenchers. In this context, oxidative stress plays
an important role in the progression of neurodegenerative conditions, including rheumatic and
cardiovascular disorders, metabolic syndrome, and other diseases [4]. Inflammation is considered
to be a risk factor for hypertension, diabetes, and several types of cancer, and can be involved in
Alzheimer’s disease pathogenesis.
Nuclear factor-kappa B (NF-κB), inducible nitric oxide synthase (iNOS), and reactive oxygen
species (ROS) have long been considered as important targets for new anti-inflammatory drugs. NF-κB
plays a central role in inflammation through its ability to induce transcription of proinflammatory
genes, hence, NF-κB has been implicated in the pathogenesis of many inflammatory and age-associated
diseases [5]. NF-κB complex proteins are widely expressed in the developing and mature nervous
system. The effects of NF-κB on neurons have been widely investigated and, recently, it has been
reported that the NF-κB family of transcription factors has a major role in regulating the growth
and elaboration of neural processes [6]. Furthermore, NF-κB has been found to play a role in
enhancing neuronal apoptosis associated with ischemic brain injury, neurodegenerative diseases,
and inflammatory conditions [7,8]. In fact, Bonini et al. [9] demonstrated that there are potential
links between the altered function of the NF-κB pathway and pathogenesis of neurodevelopmental
disorders [9]. Excessive generation of nitric oxide (NO) and ROS contribute significantly to the progress
of inflammation [10]. Inhibition of iNOS can reduce the intracellular NO production [11].
Infections caused by several protozoa microorganism, including Trypanosoma, Plasmodium, and
Leishmania, are a major worldwide health problem causing significant morbidity and mortality in
Africa, Asia, and South America. According to the World Health Organization (WHO) statistics,
there are 12 million people currently affected by leishmaniasis in 88 countries, including Algeria with
350 million people at risk [12]. Current available drugs for the treatment of these infections suffer
from high toxicities, which may cause serious side effects. Thus, there is an urgent need to develop
safer and more efficient compounds for the treatment of these diseases. Polyphenols, specifically
flavonoids, have been known to be important resources to find new antiprotozoal, non-toxic drug
candidates [13,14].
Several herbs used in folk medicine have been suggested as important sources for treatment of
depression, Alzheimer’s and Parkinson’s diseases, and other neuropsychiatric as well as neurological
disorders [15–17]. The interaction of medicinal plants with central nervous system (CNS) receptors
is well reported [18–20]. Specifically, the opioid system has been described to play different roles
in inflammation, the cancer process, and to be a potential target for therapy of various neurological
disorders [21–23]. The case of cannabinoid receptors (CB1 and CB2) has gained much attention as
potential pharmacotherapeutic targets to control some CNS disorders, in particular those related to
neuroinflammatory and neurodegenerative events, such as Alzheimer’s disease (AD) [24,25]. Within
the last decade, medicine based on opioids and cannabinoids has found many applications, including
as anti-inflammatory agents and analgesics [26,27].
Cytisus (Fabaceae) is a large and diversified genus, including approximately 60 species, which
are particularly abundant around the Mediterranean Sea [28]. Plants of this genus have been used in
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folk medicine as a diuretic and in the treatment of mild hypertension, heart failure, cardiac edema,
and wounds. Cytisus species have been found to exhibit bioactive properties, including antioxidant,
anti-inflammatory, anxiolytic, antiparasitic, and antidiabetic activities [29–31]. The therapeutic
properties of Cytisus are related to their high concentration of phenolic compounds, including
flavonoids and caffeic acids [32]. In continuation of previous works on Algerian plants [33,34], herein,
we extended our study to evaluate the antioxidant, anti-inflammatory, antiprotozoal, antimalarial,
antimicrobial, cytotoxicity, and radioligand displacement affinity on opioid and cannabinoid receptors
activities of extracts and isolated pure compounds of Cytisus villosus Pourr. (Syn. Cytisus triflorus
L’Hérit.).
2. Materials and Methods
2.1. General Experimental Procedures
UV spectra were obtained using a Perkin-Elmer Lambda 3B UV/vis-spectrophotometer (Perkin
Elmer Inc, Waltham MA, USA). 1H and 13C NMR spectra were obtained using Bruker model AMX
500 and 400 NMR spectrometers with standard pulse sequences, operating at 500 and 400 MHz in 1H
and 125 and 100 MHz in 13C, respectively. Coupling constants were recorded in Hertz (Hz). Standard
pulse sequences were used for Heteronuclear and homonuclear 2D NMR experiments. All spectra
were run at 25 ◦C. High-resolution mass spectra (HRMS) (Bruker Corporation, Billerica MA, USA)
were measured on a Micromass Q-Tof Micro mass spectrometer with a lock spray source (Waters
Corporation, Milford MA, USA). Column chromatography was carried out on silica gel (70–230 mesh,
Merck, Darmstadt, Germany), C18 Solid Phase extraction (SPE) (500 mg Bed, Thermo scientific INC,
Waltham MA, USA), Diaion HP-20 (Sorbetch technologies, Norcross GA, USA), and sephadex LH-20
(Sorbetch technologies Norcross GA, USA USA). Thin Layer Chromatography (TLC) (silica gel 60 F254,
Merck, Darmstadt, Germany) was used to monitor fractions from column chromatography. Preparative
TLC was carried out on silica gel 60 PF254+366 plates (20 × 20 cm, 1 mm thick). Visualization of the
TLC plates was achieved with a UV lamp (λ = 254 and 365 nm) and anisaldehyde/acid spray reagent
(MeOH-acetic acid-anisaldehyde-sulfuric acid, 85:9:1:5).
2.2. Plant Material
The aerial parts of Cytisus villosus Pourr. were collected from the Collo region, in Northeastern
Algeria during its flowering stage in April 2010. A voucher specimen (UM-10232015) has been deposited
in the culture collection of the Department of BioMolecular Sciences, University of Mississippi.
2.3. Extraction and Isolation
Dried powdered aerial parts of C. villosus (1 kg) were macerated at room temperature with
EtOH–H2O (80:20, v/v) for 24 h, three times. The filtered crude extracts were combined and concentrated
under reduced pressure to afford 25 g of extract, which was suspended in distilled water (800 mL)
and successively partitioned with chloroform (CHCl3), ethyl acetate (EtOAc), and n-butanol (n-but),
yielding 500 mg (CHCl3), 5 g (EtOAc), and 10 g (n-butanol) fractions, respectively. The ethyl acetate
fraction (5 g) was subjected to silica gel column, eluted initially with CH2Cl2: MeOH (95:5) and then
gradient eluted with CH2Cl2: MeOH at ratios 90:10, 85:15, 80:20, 50:50, 20:80, and finally with 100%
MeOH. Each subfraction was monitored by TLC on silica gel using CHCl3:EtOAc:HCOOH (5:4:1) and
CH2Cl2:MeOH (1:1) systems. Similar subfractions were combined together and concentrated under
reduced pressure to yield seven main subfractions (I to VII). Subfraction II (170 mg) was subjected
to Sephadex LH-20 column using MeOH as the solvent to afford compound 1 (5 mg, genistein) as
light-yellow needles. Subfraction III (161 mg) was subjected to Sephadex LH-20 using MeOH as an
eluent to yield compound 2 (4 mg) as a yellow amorphous powder. Subfraction V (250 mg) was
subjected to Sephadex LH-20 using MeOH:CH2Cl2 (1:1) as an eluent to give compound 3 (3 mg) as a
yellowish amorphous powder. The n-BuOH fraction (10 g) was subjected to Diaion HP-20 column
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chromatography and eluted with distilled H2O then MeOH to give two main subfractions, the aqueous
subfraction A (6 g) and the methanolic subfraction M (4 g). The methanolic subfraction M (4 g) was
subjected to MN-polyamide-SC-6 (150 g) column chromatography which was eluted with water and
then with water-methanol systems gradient decreased polarities to afford eight subfractions (M-1 to
M-8). Subfraction M-3 (250 mg) was rechromatographed on Sephadex LH-20 column eluted with
MeOH:CH2Cl2 (1:1) to yield compound 4 (6 mg) as yellow crystals.
2.4. Determination of Total Phenolic and Total Flavonoid Content
Folin–Ciocalteu reagent, gallic acid, and quercetin standards were obtained from Sigma-Aldrich
(Poznan, Poland). Aluminum chloride hexahydrate, methanol, and sodium carbonate were obtained
from Sigma-Aldrich (Poznan, Poland). The total phenolic was measured using spectrophotometry
with a modified Folin–Ciocalteu method [35]. Total phenol content, expressed as milligrams of gallic
acid equivalent (GAE) per gram of extract (GAE mg/g), was calculated on the basis of a standard
calibration curve of gallic acid (Y = 0.1157x + 0.087, R2 = 0.9749). Total flavonoid content of the plants
fractions crud extracts was determined by colorimetric method [36,37]. The concentration of total
flavonoid content in the test samples was calculated from the calibration plot (Y = 1.2308x + 0.0151,
R2 = 0.9775) and expressed as mg quercetin equivalent (QE)/g of dried extract. The extracts were
dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 20 mg/mL.
2.5. Antioxidant Activity
2.5.1. Diphenyl-1-picrylhydrazyl (DPPH) Assay
The antioxidant activity of the extracts and pure isolated compounds was determined by applying
the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging method [38].
2.5.2. Cellular Antioxidant Activity (CAA) Assay
The cellular antioxidant activity was measured in HepG2 cells as described by Wolfe and Rui [39,40].
The antioxidant activity was expressed in terms of CAA units. The area under the curve (AUC) of
fluorescence versus time plot was used to calculate CAA units as described by Wolfe and Rui [39,40].
2.6. Anti-Inflammatory Activity
2.6.1. Anti-Inflammatory Activity Assay for the Inhibition of iNOS
The extracts and isolated compounds of C. villosus were evaluated in terms of their interaction
with cellular targets related to inflammation and metabolic disorders, such as iNOS and NF-κB.
The inhibition of intracellular NO production as a result of iNOS activity was assayed in mouse
macrophages (RAW 264.7cells) [41]. Cytotoxicity of test samples to macrophages was also determined
in parallel to check if the inhibition of iNOS was due to cytotoxic effects.
2.6.2. Reporter Gene Assay for the Inhibition of NF-κB
Reporter gene assay for the inhibition of NF-κB Activity was performed as described earlier [42].
In brief, cells transfected with NF-κB luciferase plasmid construct were plated in 96-well plates at
a density of 1.25 × 105 cells/well. After 24 h, cells were treated with the test compounds and, after
incubating for 30 min, phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich, Burlington MA, USA)
(70 ng/mL) was added and further incubated for 6−8 h. Luciferase activity was measured as described
above. Percent decrease in luciferase activity was calculated relative to the vehicle control. Parthenolide
(Sigma-Aldrich, Burlington MA, USA) was used as a positive control.
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2.7. Antiprotozoal Assay
The in vitro antileishmanial and antitrypanosomal assays were done on cell cultures of L. donovani
promastigotes, axenic amastigotes, THP1-amastigotes, and Trypanosoma brucei trypomastigotes by
Alamar Blue assays [43]. The conditions for seeding the THP1 cells, exposure to the test samples,
and evaluation of cytotoxicity were the same as described in parasite-rescue and transformation
assay [44]. IC50 and IC90 values were computed from the dose response curves using XLfit software
(XLfit 5.3.1, IDBS analytical, Boston MA, USA). DFMO (difluoromethylornithine) was used as the
positive control. The antiprotozoal activity of C. villosus extracts and isolated compounds were
evaluated in vitro against L. donovani promastigotes, axenic amastigotes, and intracellular amastigotes
in THP1 cells. The extracts and some isolated compounds were also evaluated against T. brucei
trypomastigote forms. All the extracts and compounds were simultaneously tested against THP1 cell
for determination of general cytotoxicity. The extracts and isolated compounds were also evaluated for
their antimalarial activity against chloroquine-sensitive (D6, Sierra Leone) and chloroquine-resistant
strains (W2, Indochina) strains of Plasmodium falciparum [45]. Furthermore, they were tested for
cytotoxicity against the Vero cell line.
2.8. Antimicrobial Assay
Extracts and pure compounds were tested for their antimicrobial activity against Staphylococcus
aureus, methicillin-resistant S. aureus (MRSA), Escherichia coli, Pseudomonas aeruginosa, and Mycobacterium
intracellulare. The antifungal activities were evaluated against a panel of pathogenic fungi, including
Candida albicans, C. glabrata, C. krusei, Aspergillus fumigatus, and Cryptococcus neoformans, associated
with opportunistic infections. Ciprofloxacin (MP Biomedicals Inc, Aurora OH, USA) for antibacterial
bioassays and Amphotericin B (MP Biomedicals Inc, Aurora OH, USA) for fungal bioassays were used
as positive controls, respectively [45].
2.9. Cytotoxicity Assays
Each assay was performed in 96-well tissue culture-treated microplates. Cytotoxic activity
was determined against four human cancer cell lines (SK-MEL, KB, BT-549, andSKOV-3,) and two
noncancerous kidney cell lines (LLC-PK1 and Vero). All cell lines were obtained from the American
Type Culture Collection (ATCC, Rockville, MD, USA). Each assay was performed in 96-well tissue
culture-treated microplates [46]. Cells were seeded at a density of 25,000 cells/well and incubated for
24 h. Samples at different concentrations were added and cells were again incubated for 48 h. At the
end of incubation, the cell viability was determined using neutral red dye according to a modification
of the procedure of Borenfreund et al. [46,47]. IC50 values were determined from dose−response curves
of percent growth inhibition against test concentrations. Doxorubicin was used as a positive control,
while DMSO was used as the negative (vehicle) control.
2.10. Radioligand Displacement for Cannabinoid and Opioid Receptor Subtypes
The evaluated extracts and isolated compounds of C. villosus were run in competition binding
with cannabinoid receptor subtypes, cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2),
and were tested against the opioid receptor subtypes (µ, κ, and δ) as previously described [48].
2.11. Statistical Analysis
All the experiments for determination of total phenolics, total flavonoids, and antioxidant
properties using DPPH and cellular antioxidant assay (CAA) were conducted in triplicates. The values
are expressed as the mean ± standard deviation (SD). Analysis of variance and significance of difference
among means were tested by one-way ANOVA and least significant difference (LSD) on mean values.
Correlation coefficients (R) and coefficients of determination (R2) were calculated using Microsoft
Excel 2007.
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3. Results
3.1. Chemistry
Phytochemical study of the hydro ethanolic extract of the aerial part of C. villosus led to the
isolation of four known flavonoids (1) genistein, (2) chrysin, (3) chrysin-7-O-β-d-glucopyranoside,
and (4) 2”-O-α-l-rhamnosylorientin (Figure 1). The structures of the known compounds were identified
by comparison of their spectroscopic data with those reported in the literature [33]. The spectroscopic
data for the isolated compounds can be seen the Supplementary Materials Figures S1–S12.
Biomolecules 2019, 9, x 6 of 16 
3.1. Chemistry 
Phytochemical study of the hydro ethanolic extract of the aerial part of C. villosus led to the 
isolation of four known flavonoids (1) genistein, (2) chrysin, (3) chrysin-7-O-β-D-glucopyranoside, 
and (4) 2"-O-α-L-rhamnosylorientin (Figure 1). The structures of the known compounds were 
identified by comparison of their spectroscopic data with those reported in the literature [33]. The 




























Chrysin -7-O- -D-glucopyranoside (3) 2"-O- -L-rhamnosylorientin (4)  
Figure 1. Compounds isolated of Cytisus villosus aerial parts.  
3.2. Determination of Total Phenolic and Total Flavonoid Contents 
Table 1 shows the total phenolic content in the extracts of the C. villosus aerial parts. Total 
phenolic content was measured for the CHCl3, EtOAc, and n-BuOH extracts. Among the extracts of 
C. villosus, the highest phenolic content was found in the n-BuOH extract (363.00mg GAE/g dried 
extract) followed by EtOAc (208.00 mg GAE/g dried extract) and CHCl3 extract (56.00 mg GAE/g 
dried extract). The total flavonoids content in the C. villosus extracts are shown in Table 1. Similarly, 
the highest amount of flavonoid content was found in the n-BuOH extract (21.16 mg QE/g dried 
extract).  








Content (mg QE/g 
extract) 
DPPH Scavenging IC50 





CHCl3 56.0 ± 2.50 7.70 ± 0.547 0.459 ± 0.002 2.180 ± 0.01 0.093 ± 0.004 
EtOAc 208.0 ± 8.49 13.95 ± 1.058 0.425 ± 0.003 2.355 ± 0.018 0.100 ± 0.001 
n-BuOH 363.0 ± 8.32 21.16 ± 1.022 0.164 ± 0.004 6.113 ± 0.157 0.268 ± 0.007 
Ascorbic acid    0.043 ± 0.006 23.761 ± 3.257  
Values expressed are means ±SD of three parallel measurements. GAE. Gallic acid equivalents; QE. 
Quercetin equivalents; ARP. Antiradical power. 
3.3. Determination of Antioxidant Activity 
Figure 1. Compounds isolated of Cytisus villosus aerial parts.
3.2. Determination of Total Phenolic and Total Flavonoid
Table 1 shows the otal phenolic content in he extracts of he C. villosus aerial parts. Total phenolic
content was measured for the CHCl3, EtOAc, and n-BuOH extracts. Among the extracts of C. villosus,
the highest phenolic content was found in the n-BuOH extract (363.00mg GAE/g dried extract) followed
by EtOAc (208.00 mg GAE/g dried extract) and CHCl3 extract (56.00 mg GAE/g dried extract). The total
flavonoids content in the C. villosus extracts are shown in Table 1. Similarly, the highest amount of
flavonoid content was found in the n-BuOH extract (21.16 mg QE/g dried extract).
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3.3. Determination of Antioxidant Activity
3.3.1. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Assay
The antioxidant activity of extracts and isolated compounds of C. villosus was evaluated in terms
of their free radical scavenging capacity (DPPH) assay (Figure 2). The CHCl3 and EtOAc extracts of C.
villosus showed moderate antioxidant activity with IC50 values of 0.459 and 0.425 mg/mL, respectively.
The n-BuOH extract showed highly antioxidant activity against DDPH compared to EtOAc and CHCl3
extracts with an IC50 value of 0.164 mg/mL (Table 1).
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3.3.2. Cellular Antioxidant Activity (CAA) assay
The antioxidant activity of C. villosus extracts and isolated pure compounds was also evaluated
using the cellular antioxidant assay (CAA). The results are shown in Table 2. The extracts of C. villosus
showed weak inhibition of intracellular oxidative stress (29% to 36% inhibition of ROS generation at
250 µg/mL). Similarly, the tested isolated compounds were not effective except for compound 4 from
n-BuOH extract (Figure 2). Compound 4 showed weak inhibition of intracellular oxidative stress (28%
at 250 µg/mL) (Table 2).
3.4. Determination of Anti-Inflammatory Activity
The EtOAc and n-BuOH extracts of C. villosus showed weak inhibition of iNOS with IC50 values
of 48 and 90 µg/mL, respectively. Compounds 1 and 3 isolated from the EtOAc extract of C. villosus
showed good inhibition of iNOS with IC50 values of 9 and 20 µg/mL, respectively (Table 3). The increase
in transcriptional activity of NF-κB in PMA-treated cells was also not suppressed by the plant’s extracts
and isolated compounds with the exception of compounds 1 and 2, which showed moderate inhibition
of NF-κB activity with IC50 values of 28 and 38 µg/mL, respectively (Table 3).
Biomolecules 2019, 9, 732 8 of 16
Table 2. Potential antioxidant activities of extracts and some isolated pure compounds.
% Decrease in Oxidative Stress
Tested Organism Concentration (µg/mL)
1000 500 250
xtracts
EtOAc 47 37 29
n-BuOH 49 39 36
Compounds
1 NA NA NA
2 NA NA NA
3 NA NA NA
4 36 29 28
Quercetin 25 µM 77
Table 3. Anti-inflammatory activities of extracts and some isolated compounds of C. villosus.






EtOAc 48 NT NT
n-BuOH 90 NT NT
compounds
1 9 28 NA
2 >25 38 NA
3 20 NA NA
4 NA NA NA
Parthenolide 0.2 1.63
NA = no activity at 25 or 100 µg/mL for pure compounds and extracts, respectively. NT = not tested.
3.5. Antiprotozoal Activity
The results for this assay are presented in Table 4. The EtOAc extract showed weak
antitrypanosomal activity against T. brucei with IC50 values of 19.48 µg/mL, while the n-BuOH
extract was found to exhibit high antitrypanosomal activity against T. brucei with IC50 values of
7.99 µg/mL and IC90 values of 12.61 µg/mL. No significant activity was observed in vitro against
Leishmania donovani (promastigotes, axenic amastigotes, and intracellular amastigotes in THP1 cells).
3.6. Antimicrobial Activity
The plant’s extracts and isolated compounds showed no antimicrobial activity against all tested
microorganisms. The results of antimicrobial assay are given in Table 5.
3.7. Anti-Malarial Activity
The results of the antimalarial activity assay are presented in Tables 6 and 7. No antimalarial
activity was observed against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium.
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Table 5. Antimicrobial activity of extracts and certain isolated compounds of C. villosus
% Growth Inhibition 1,2/IC50 µg/mL
Anti-Fungal Anti-Bacterial
Extract/
Compound C. albicans C. glabrata C. krusei A. fumigatus C. neoformans S. aureus MRSA E. coli P. aeruginosa
n-BuOH 9 40 0 2 0 0 0 14 9
EtOAc 9 11 2 4 0 3 0 12 5
2 >20 NT NT NT >20 >20 NT >20 >20
3 >20 NT NT NT >20 >20 NT >20 >20
4 >20 NT NT >20 >20 >20 >20 >20 >20
AMB 100 NT NT 93 100 NT 1 0 0
CIPRO 0 NT NT 8 0 NT 0 100 96
Concentration: 50 µg/mL. 1 Samples showing % Growth Inhibition <50 are considered inactive; 2 Samples showing % Growth Inhibition >50 in any organisms are confirmed in secondary
assay. Ciprofloxacin (CIPRO) and Amphotericin (AMB) = positive controls. Pure compounds that have an IC50 of ≤7 µg/mL in the secondary assay proceeded to the tertiary assay.
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Table 6. Antimalarial activity of C. villosus extracts.
Tested Organism %Inhibition
Extract P. falciparum (D6 Clone) P. falciparum (W2 Clone) Concentration ng/mL
BuOH 0 NT 158667
EtOAc 0 NT 158667
CQ 100 NT 79.3
CQ: Chloroquine (Positive Control).
Table 7. Antimalarial activity (IC50 values are in ng/mL) of compound.
IC50 SI IC50 SI IC50
CQ <26.0 >9 116 >2.1 >238 238-26.4
2 >4760 1 >4760 1 >4760 4760-528.9
3 >4760 1 >4760 1 >4760 4760-528.9
CQ: Chloroquine (Positive Control); SI: selectivity index (IC50 for cytotoxicity/IC50 for antimalarial activity).
3.8. Cytotoxicity
The results of Cytotoxicity assays are shown in Table 8. The tested extracts and isolated compounds
of C. villosus were not active against any cell lines used in this study.
Table 8. Cytotoxic activity of C. villosus extracts and isolated pure compounds
Cytotoxicity (IC50 µg/mL)
Extract/Compound SK-MEL KB BT-549 SK-OV-3 LLC-PK1 Vero
EtOAc NA NA NA NA NC NC
BuOH NA NA NA NA NC NC
3 NA NA NA NA NC NC
doxorubicin 0.8 1.3 0.9 2 1.2 NC
IC50 is the concentration that affords 50% inhibition of cell growth. SK-MEL: Human malignant melanoma;
KB: Human epidermoid carcinoma; BT-549: Human ductal carcinoma; SK-OV-3: Human ovary carcinoma;
LLC-PK-1: Pig kidney epithelial cells; Vero: African green monkey kidney cell line. NA = No activity at 100 µM.
NC = Not cytotoxic.
3.9. Radioligand Displacement for Cannabinoid and Opioid Receptor Subtypes
The affinity of the total extracts and isolated compounds towards cannabinoid and opioid receptors
was tested. The results are shown in Table 9. Low affinity for cannabinoids was found in both extracts
evaluated and no affinity for the compound 2. For opioids, both fractions tested revealed a preference
toward δ-opioids with low displacement values.
Table 9. Displacement radioligand assay for human opioid receptors (Subtypes δ, κ, and µ) and
cannabinoid receptors (Subtypes CB1 and CB2) of C. villosus.
Cannabinoid Receptors (%) Opioid Receptors (%)
Extract/Compound CB1 CB2 δ κ µ
EtOAc 32.1 25.2 31.3 5.7 2.8
n-BuOH 33.7 26.1 24.8 10.3 5.7
2 7.7 0.8 8.7 12.8 12.2
naloxone 106.4 101.6 97.0
CP 55,940 104.3 102.6
Naloxone and CP 55,940 = Positive controls.
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4. Discussion
The antioxidant capacity of medicinal plants extracts and pure natural compounds can be tested
using various methods. In the present study, the antioxidant activity of the studied species extracts and
its isolated phenolics were evaluated in terms of their free radical scavenging capacity by DPPH assay.
Their activity against intracellular oxidative stress was determined by CAA assay. Our results showed
that the radical scavenging activity of the n-BuOH extract of C. villosus aerial parts was high compared
to the EtOAc and CHCl3 extracts. The n-BuOH extract was found to have the highest inhibition of
intracellular oxidative stress with 36% inhibition at 250 µg/mL.
The relationship between total phenolic content and total flavonoid and antioxidant activity
using DPPH assay of different extracts is shown in Figures 3 and 4, respectively. Regression analysis
showed that phenolic compounds contributed to about 74% (R2 = 0.744, p< 0.05) of radical scavenging
properties in the extracts of C. villosus (Figure 4). Similarly, flavonoid compounds contributed to
about 74% (R2 = 0.736, p < 0.05) of antioxidant activity in the extracts (Figure 4). Figure 5 shows the
comparison between total phenolic and total flavonoid contents (TPC and TF, respectively) and radical
scavenging potential (DPPH) expressed in (IC50) data in different extracts of C. villosus. Figure 5 also
shows that the n-BuOH extract exhibited the highest radical scavenging potential (DPPH) expressed in
(IC50). Hence, a high phenolic content is an important factor to determinate the antioxidant activity.
This result is in agreement with previous studies, reporting that the phenolic compounds significantly
contribute to the antioxidant activity in different plant species [49].
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In contrast to the antioxidant assays results, the n-BuOH extract from the C. villosus aerial parts
showed weak anti-inflammatory activity for the inhibition of iNOS expression, with an IC50 value
of 90 µg/mL. Whereas the EtOAc extract exhibited higher inhibition of iNOS with an IC50 value of
48 µg/mL. The increase in transcriptional activity of NF-κB in PMA-treated cells was not suppressed
by the plant’s extracts. Among all tested compounds, compound 1 from the EtOAc extract showed
good inhibition of iNOS with an IC50 value of 9 µg/mL. Thi compound showed lower inhibition
of NF-κB activity with an IC50 value of 28 µg/mL. Previous studies also indicated that genistein (1)
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acts as anti-inflammatory agent [50]. This isoflavone has been reported to have inhibitory effects on
iNOS expression and to inhibit the activation of nuclear factor-κB (NF-κB) [51,52]. Hence, the EtOAc
extract could be a good source of phenolics with anti-inflammatory activity. Our results also showed
that n-BuOH extract exhibited potent antitrypanosomal activity against T. brucei with an IC50 value
of 7.99 µg/mL and an IC90 value of 12.61 µg/mL. Compound 4 that was isolated from this extract
didn’t show an effect against T. brucei. Future examination of the polar components of C. villosus, shall
determine the active components from the n-BuOH extract.
The opioid system consists of three receptors, mu, delta, and kappa, which are activated
by endogenous opioid peptides (enkephalins, endorphins, and dynorphins). The endogenous
cannabinoid system comprises lipid neuromodulators (endocannabinoids), enzymes for their synthesis
and their degradation, and two well-characterized receptors, cannabinoid receptors CB1 and CB2 [53].
Evidence has suggested that the opioid system can regulate inflammatory responses in rodents [54].
Mastinou et al. [25], recently described the link between neuroinflammation and cannabinoid systems.
The radioligand displacement affinity towards opioid and cannabinoid receptors were evaluated
for the extracts and isolated compounds of C. villosus. The EtOAc extract exhibited low/moderate
activity towards the CB1 and CB2 receptors (32.1% and 25.2% displacement) and moderate activity
in the delta (δ) opioid receptor (31.3% displacement). Similarly, the n-BuOH extract was found to
have moderate activity towards CB1, CB2, and delta (δ) opioid receptors (33.7%, 26.1% and 24.8%
displacement, respectively). None of the isolated compounds showed activity towards cannabinoid
nor opioid receptors.
5. Conclusions
In conclusion, we reported the phenolic and flavonoid content, antioxidant, anti-inflammatory,
antibacterial, antifungal, antimalarial, antitrypanosomal, antileishmanial, and cytotoxicity activities, in
addition to the affinity towards cannabinoid and opioid receptors, of C. villosus aerial parts extracts
and their isolated compounds. Our results showed that the n-BuOH extract had the highest phenolic
and flavonoid content. Furthermore, n-BuOH extract produced a potent antitrypanosomal activity that
makes it a promising source for the extraction of bioactive components with high activity against human
African trypanosomiasis. EtOAc extract was found to exhibit moderate anti-inflammatory activity
against iNOS, while the n-BuOH extract showed lower inhibitory effect against iNOS. Among isolated
compounds, genistein, which isolated from the EtOAc extract, showed the highest anti-inflammatory
activity. Further explorations of EtOAc extract could afford more potent anti-inflammatory agents.
Although the EtOAc and n-BuOH extracts showed moderate activity towards CB1, CB2, and δ opioid
receptors, these results encourage further exploration of Cytisus species and its isolated compounds to
study their cannabinoid and opioid receptors activities.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/9/11/732/s1,
Figures S1–S12, spectroscopic data for the isolated compounds.
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